Hematology TimesLonger duration of triple therapy confers no benefit, trial suggestsSeptember 19, 2014Thrombosis
Hematology TimesMost VTE therapies produce comparable results, analysis suggestsSeptember 17, 2014Thrombosis
Hematology TimesFDA approves treatment for kids with hemophilia BSeptember 17, 2014ThrombosisPediatricsPharmacy
Hematology TimesHemostats may decrease costs, use of resourcesSeptember 16, 2014ThrombosisBlood Banking
Hematology TimesNICE recommends eculizumab for aHUS despite costSeptember 10, 2014AnemiaThrombosisPharmacy
Hematology TimesPreclinical results support blood transfusions containing fibronectinSeptember 3, 2014ThrombosisBlood Banking
